 | Biotech Stock Roundup: Label Expansion for CELG's Drugs, Setback for IMGN - Yahoo Finance
finance.yahoo.com - May 22 at 4:30 PM |
 | ImmunoGen: Assessing The Possibility Of A Turnaround
seekingalpha.com - May 18 at 10:31 AM |
 | Q3 2019 Earnings Estimate for ImmunoGen, Inc. (IMGN) Issued By William Blair
www.americanbankingnews.com - May 17 at 6:43 AM |
| ImmunoGen (IMGN) Price Target Cut to $4.00 by Analysts at HC Wainwright
www.americanbankingnews.com - May 16 at 4:58 PM |
| Why Immunogen Was Down by More than 30% on May 15
finance.yahoo.com - May 16 at 4:23 PM |
| What Analysts Recommend for IMGN after Its Q1 Results
finance.yahoo.com - May 16 at 4:23 PM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunoGen, Inc. IMGN - Yahoo Finance
finance.yahoo.com - May 16 at 8:49 AM |
 | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunoGen, Inc. IMGN - GlobeNewswire
www.globenewswire.com - May 15 at 9:32 PM |
| ImmunoGen Announces Mature Data from FORWARD II Expansion Cohort Evaluating Mirvetuximab Soravtansine in Combination with Avastin® in Ovarian Cancer
finance.yahoo.com - May 15 at 9:32 PM |
| SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ImmunoGen, Inc. IMGN
finance.yahoo.com - May 15 at 9:32 PM |
 | Why The Children's Place, Agilent Technologies, and Immunogen Slumped Today
www.fool.com - May 15 at 4:41 PM |
 | ImmunoGen stock down more than 30% after FDA suggests conducting new Phase 3 trial for ovarian cancer drug - MarketWatch
www.marketwatch.com - May 15 at 4:26 PM |
| Guggenheim Downgrades ImmunoGen (IMGN) to Neutral
www.americanbankingnews.com - May 15 at 12:25 PM |
| Catalyst Pharmaceuticals and Genetic Technologies among healthcare gainers; ImmunoGen leads the losers - Seeking Alpha
seekingalpha.com - May 15 at 11:28 AM |
| ImmunoGen Provides Regulatory Update on Mirvetuximab Soravtansine Monotherapy in Ovarian Cancer
finance.yahoo.com - May 15 at 11:28 AM |
| ImmunoGen stock down more than 30% after FDA suggests conducting new Phase 3 trial for ovarian cancer drug
finance.yahoo.com - May 15 at 11:28 AM |
| ImmunoGen Plunges as FDA Rejects Fast-Track Approval for Cancer Drug
finance.yahoo.com - May 15 at 11:28 AM |
| ImmunoGen (IMGN) Misses on Earnings & Revenues in Q1 - Yahoo Finance
finance.yahoo.com - May 8 at 11:23 AM |
 | ImmunoGen (IMGN) Misses on Earnings & Revenues in Q1 - Nasdaq
www.nasdaq.com - May 7 at 4:30 PM |
| $10.82 Million in Sales Expected for ImmunoGen, Inc. (IMGN) This Quarter
www.americanbankingnews.com - May 7 at 3:57 AM |
| ImmunoGen and Athenex among healthcare gainers; AAC Holdings and PetMed Express among losers - Seeking Alpha
seekingalpha.com - May 6 at 4:27 PM |
| ImmunoGen (IMGN) Rating Increased to Outperform at Cowen
www.americanbankingnews.com - May 6 at 12:01 PM |
| ImmunoGen (IMGN) Upgraded at HC Wainwright
www.americanbankingnews.com - May 6 at 11:05 AM |
 | UPDATE: HC Wainwright Upgrades Immunogen Inc. (IMGN) to Buy - StreetInsider.com
www.streetinsider.com - May 6 at 10:33 AM |
| Is ImmunoGen, Inc. (IMGN) A Good Stock To Buy? - Yahoo Finance
finance.yahoo.com - May 6 at 10:33 AM |
| ImmunoGen (IMGN) Misses on Earnings & Revenues in Q1
finance.yahoo.com - May 6 at 10:32 AM |
| Zacks: Analysts Anticipate ImmunoGen, Inc. (IMGN) to Post -$0.28 EPS
www.americanbankingnews.com - May 5 at 4:53 PM |
| ImmunoGen (IMGN) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance
finance.yahoo.com - May 4 at 11:24 AM |
| Immunogen Inc. (IMGN) CEO Mark Enyedy on Q1 2019 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 4 at 11:24 AM |
| Edited Transcript of IMGN earnings conference call or presentation 3-May-19 12:00pm GMT
finance.yahoo.com - May 4 at 11:24 AM |
| ImmunoGen (IMGN) Issues Quarterly Earnings Results, Beats Expectations By $0.01 EPS
www.americanbankingnews.com - May 3 at 8:38 PM |
| ImmunoGen Q1 top line off 57%; shares down 4% premarket - Seeking Alpha
seekingalpha.com - May 3 at 4:23 PM |
| Immunogen Inc (IMGN) Q1 2019 Earnings Call Transcript - Yahoo Finance
finance.yahoo.com - May 3 at 4:23 PM |
| Immunogen Inc (IMGN) Q1 2019 Earnings Call Transcript
www.fool.com - May 3 at 2:58 PM |
| Form 8-K IMMUNOGEN INC For: May 03 - StreetInsider.com
www.streetinsider.com - May 3 at 11:32 AM |
| ImmunoGen (IMGN) Reports Q1 Loss, Lags Revenue Estimates
finance.yahoo.com - May 3 at 11:32 AM |
| ImmunoGen, Inc. (IMGN) to Post Q1 2020 Earnings of ($0.43) Per Share, William Blair Forecasts
www.americanbankingnews.com - May 3 at 10:37 AM |
| ImmunoGen, Inc. (NASDAQ:IMGN): What Are The Future Prospects? - Yahoo Finance
finance.yahoo.com - May 2 at 4:24 PM |
| ImmunoGen, Inc. (NASDAQ:IMGN): What Are The Future Prospects?
finance.yahoo.com - May 2 at 4:24 PM |
| ImmunoGen, Inc. (IMGN) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - April 30 at 2:26 AM |
| Analysts Estimate ImmunoGen (IMGN) to Report a Decline in Earnings: What to Look Out for - Yahoo Finance
finance.yahoo.com - April 26 at 4:20 PM |
| Analysts Estimate ImmunoGen (IMGN) to Report a Decline in Earnings: What to Look Out for
finance.yahoo.com - April 26 at 4:20 PM |
| ImmunoGen Announces Conference Call to Discuss Its First Quarter 2019 Operating Results
finance.yahoo.com - April 19 at 11:33 AM |
 | ImmunoGen Stock Is in Trouble Going Into Earnings
investorplace.com - April 15 at 2:18 PM |
| Noteworthy Friday Option Activity: IMGN, SPWR, MMM - Nasdaq
www.nasdaq.com - April 12 at 6:08 PM |
| Here's Why ImmunoGen Tumbled 43% in March - Motley Fool
www.fool.com - April 9 at 1:11 PM |
| Do Directors Own ImmunoGen, Inc. (NASDAQ:IMGN) Shares?
finance.yahoo.com - March 27 at 12:31 PM |
| ImmunoGen (IMGN) Down 50.2% Since Last Earnings Report: Can It Rebound?
finance.yahoo.com - March 10 at 10:52 AM |
| Biotech Analysis Central Pharma News: Evoke's Mishap, ImmunoGen's Struggle, Eli Lilly's Priority Review
seekingalpha.com - March 8 at 4:26 PM |
| Immunogen Ovarian Cancer Drug Fails in Phase III, Stock Sinks - Yahoo News
finance.yahoo.com - March 6 at 4:25 PM |
